Veterinary Biologics Market

The report "Veterinary Biologics Market by Product (Monoclonal Antibodies, Diagnostic Kits, Immunoglobulins & Antitoxins), RoA (Injectable, Oral), Application (Infectious Disease Prevention, Dermatology, Pain Management), Animal, End User - Global Forecast to 2030", is expected to reach USD 3.51 billion by 2030 from USD 2.72 billion in 2025, at a CAGR of 5.2%, during the forecast period.

Browse 312 market data Tables and 61 Figures spread through 316 Pages and in-depth TOC on "Veterinary Biologics Market by Product (Monoclonal Antibodies, Diagnostic Kits, Immunoglobulins & Antitoxins), RoA (Injectable, Oral), Application (Infectious Disease Prevention, Dermatology, Pain Management), Animal, End User - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/veterinary-biologics-market-4768999.html

The veterinary biologics market is experiencing steady growth, driven by increasing rates of chronic diseases in animals and rising pet ownership. Common conditions such as atopic dermatitis and osteoarthritis pain are widespread among companion animals, requiring effective treatment options. Several approved biologic products, such as Cytopoint, Librela, Solensia, Gilvetmab, and Canine Parvovirus Monoclonal Antibody (CPMA), have gained significant traction, greatly contributing to market expansion. Additionally, technological advancements are playing a crucial role in improving patient outcomes. Innovations in biologic therapeutics, diagnostic tools, and the rise of teledermatology are transforming veterinary care. Growing awareness among pet owners, broader pet insurance coverage, and increased R&D investments are further driving the market, fostering innovation and expanding treatment options.

"By product type, the monoclonal antibodies segment is expected to grow at the fastest rate in the global veterinary biologics market during the forecast period."

By animal type, monoclonal antibodies are expected to register a high growth rate in the veterinary biologics market, driven by their targeted mechanism of action, high efficacy, and increasing adoption in livestock health management. These biologics are increasingly used to prevent and treat specific diseases by precisely targeting pathogens or toxins, offering a more selective and effective alternative to traditional therapies such as antibiotics. In livestock applications, monoclonal antibodies are particularly valuable for conditions that require rapid immune support, leading to reduced morbidity and improved productivity. Their use supports the global shift toward sustainable animal farming practices and the reduction of antimicrobial resistance (AMR), positioning them as a preferred choice in advanced biologic interventions.

"By application, the dermatology segment accounted for the largest share of the global veterinary biologics market."

The dermatology segment is projected to hold the largest share in the veterinary biologics market due to the increasing prevalence of skin disorders in companion and livestock animals, such as allergies, bacterial and fungal infections, and parasitic infestations. Rising pet ownership and greater awareness about animal health are fueling demand for advanced biologics, including vaccines, immunotherapies, and monoclonal antibodies for dermatological issues. Innovations in biologics that provide long-lasting efficacy with minimal side effects further promote adoption. Additionally, higher healthcare spending on animals, along with the expansion of veterinary clinics and hospitals, contributes to this segment's growth. The availability of targeted biologics for chronic skin conditions is also expected to improve treatment outcomes. All these factors collectively establish dermatology as the leading application segment in the veterinary biologics market.

“By region, the North America region accounted for the largest share during the forecast period.”

The region’s rapid market growth is due to the increasing pet population, heightened awareness of animal health, and higher spending on veterinary care. Also, advanced veterinary healthcare infrastructure and the presence of key market players are further boosting growth in countries such as China, India, and Japan. Livestock farming also significantly contributes to the region's economy. Countries such as India and China have large numbers of livestock animals, driven by the rising demand for meat, milk, and other animal-based products.

Key Market Players

Prominent players in the veterinary biologics market are Zoetis Services LLC (US), IDEXX (US), Elanco (US), Merck & Co., Inc. (US), Thermo Fisher Scientific Inc. (US), Boehringer Ingelheim International GmbH (Germany), Neogen Corporation (US), Bio-Rad Laboratories, Inc. (US), ImmuCell Corporation (US), and Innovative Diagnostics (France).

Don’t miss out on business opportunities in Veterinary Biologics Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/